{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:19:27Z","timestamp":1787804367421,"version":"build-2784847793"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Abstract.<\/jats:title>\n                    <jats:p>Solid organ transplant recipients face an increased risk of human papillomavirus (HPV)\u2013associated anal cancer because of chronic immunosuppression and impaired viral control. The natural history and underlying biology of anal dysplasia in this population remain poorly defined, and current management is largely extrapolated from human immunodeficiency virus\u2013associated disease. Transplant-related immune dysfunction differs fundamentally from other immunocompromised states, with direct effects on T-cell activation, antigen presentation, and immune memory that are central to HPV control. In this overview, we integrate insights from HPV-driven carcinogenesis, HIV-associated anal disease, and transplant immunology to propose a transplant-specific framework of mucosal immune dysfunction. In this model, HPV immune evasion synergizes chronic immunosuppression to impair antiviral cellular immunity, promoting persistent infection, and a protumorigenic microenvironment characterized by T-cell dysfunction, impaired antigen presentation, regulatory immune polarization, and metabolic reprogramming. These processes are hypothesized to facilitate progression to high-grade squamous intraepithelial lesions, the immediate precursor to anal cancer. This framework provides a biologic basis to interpret clinically observed persistence and recurrence of anal dysplasia in solid organ transplant recipients, highlights key knowledge gaps and may inform transplant-specific screening, therapeutic strategies, and prospective studies in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005891","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:00:21Z","timestamp":1787803221000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["HPV-associated Anal Dysplasia in Solid Organ Transplant Recipients: A Transplant-specific Model of Mucosal Immune Dysfunction"],"prefix":"10.1097","author":[{"given":"Edward R.","family":"Cachay","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Mayo Clinic Arizona, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Colorectal Surgery, Mayo Clinic Arizona, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holenarasipur R.","family":"Vikram","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Mayo Clinic Arizona, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Nagarakanti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Mayo Clinic Arizona, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Alasfar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Mayo Clinic Arizona, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, Mayo Clinic Arizona, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Biodesign Institute, Arizona State University, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"R1-20260827","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnci\/djad214","article-title":"Human papillomavirus-associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates-United States, 2001-2019.","volume":"116","author":"Gopalani","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"R2-20260827","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R3-20260827","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale.","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"key":"R4-20260827","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1111\/ajt.15942","article-title":"Burden of anal squamous cell carcinoma, squamous intraepithelial lesions and HPV16 infection in solid organ transplant recipients: a systematic review and meta-analysis.","volume":"20","author":"Albuquerque","year":"2020","journal-title":"Am J Transplant"},{"key":"R5-20260827","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/hiv.12190","article-title":"Five-year cumulative incidence of invasive anal cancer among HIV-infected patients according to baseline anal cytology results: an inception cohort analysis.","volume":"16","author":"Cachay","year":"2015","journal-title":"HIV Med"},{"key":"R6-20260827","doi-asserted-by":"crossref","first-page":"101423","DOI":"10.1016\/j.mam.2025.101423","article-title":"Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment services.","volume":"107","author":"Hall","year":"2026","journal-title":"Mol Aspects Med"},{"issue":"30 Suppl 5","key":"R7-20260827","doi-asserted-by":"crossref","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses.","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine"},{"key":"R8-20260827","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.20122394","article-title":"The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter.","volume":"210","author":"Hasan","year":"2013","journal-title":"J Exp Med"},{"key":"R9-20260827","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2015.05.029","article-title":"Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: a case-control study.","volume":"138","author":"Aggarwal","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R10-20260827","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI129497","article-title":"HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING.","volume":"130","author":"Luo","year":"2020","journal-title":"J Clin Invest"},{"key":"R11-20260827","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MS9.0000000000004352","article-title":"Inflammation, immunity, and invasion: the pivotal role of cytokine storms in cervical carcinogenesis.","volume":"88","author":"Obeagu","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"R12-20260827","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.07.044","article-title":"HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells.","volume":"407","author":"Campo","year":"2010","journal-title":"Virology"},{"key":"R13-20260827","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fimmu.2020.00323","article-title":"The crosstalk between hippo-YAP pathway and innate immunity.","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"R14-20260827","first-page":"266","article-title":"Immune responses to human papilloma viruses.","volume":"130","author":"Stanley","year":"2009","journal-title":"Indian J Med Res"},{"issue":"1 Suppl","key":"R15-20260827","first-page":"s12","article-title":"An overview of immunosuppression in solid organ transplantation.","volume":"21","author":"Enderby","year":"2015","journal-title":"Am J Manag Care"},{"key":"R16-20260827","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0105-2896.2010.00898.x","article-title":"The role of mTOR in memory CD8 T-cell differentiation.","volume":"235","author":"Araki","year":"2010","journal-title":"Immunol Rev"},{"key":"R17-20260827","doi-asserted-by":"crossref","first-page":"1591297","DOI":"10.3389\/fimmu.2025.1591297","article-title":"Immune responses to human papillomavirus infection and vaccination.","volume":"16","author":"Kiamba","year":"2025","journal-title":"Front Immunol"},{"key":"R18-20260827","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fonc.2019.00682","article-title":"Papillomavirus immune evasion strategies target the infected cell and the local immune system.","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Oncol"},{"key":"R19-20260827","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/ijc.28309","article-title":"Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma.","volume":"133","author":"de Vos van Steenwijk","year":"2013","journal-title":"Int J Cancer"},{"key":"R20-20260827","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4049\/jimmunol.1100889","article-title":"van der Burg SH. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.","volume":"187","author":"Heusinkveld","year":"2011","journal-title":"J Immunol"},{"key":"R21-20260827","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2005.02282.x","article-title":"High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans\u2019 cells in the human female genital tract.","volume":"117","author":"Jimenez-Flores","year":"2006","journal-title":"Immunology"},{"key":"R22-20260827","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation.","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"R23-20260827","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1128\/JVI.00974-10","article-title":"The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis.","volume":"84","author":"Spangle","year":"2010","journal-title":"J Virol"},{"key":"R24-20260827","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/carcin\/bgw086","article-title":"mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6\/E7 mouse model.","volume":"37","author":"Callejas-Valera","year":"2016","journal-title":"Carcinogenesis"},{"key":"R25-20260827","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","article-title":"von Knebel Doeberitz M. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.","volume":"68","author":"Vinokurova","year":"2008","journal-title":"Cancer Res"},{"key":"R26-20260827","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer.","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"R27-20260827","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.3390\/cancers17223627","article-title":"T cell exhaustion in the cervical cancer tumor microenvironment: PD-1 overexpression and Co-expression with TIGIT, Tim-3, LAG-3, and NKG2A.","volume":"17","author":"Garc\u00eda-Barrientos","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R28-20260827","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1158\/0008-5472.CAN-18-0163","article-title":"Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer.","volume":"78","author":"Krishna","year":"2018","journal-title":"Cancer Res"},{"key":"R29-20260827","doi-asserted-by":"crossref","first-page":"e1128612","DOI":"10.1080\/2162402X.2015.1128612","article-title":"High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women.","volume":"5","author":"Papasavvas","year":"2016","journal-title":"Oncoimmunology"},{"key":"R30-20260827","doi-asserted-by":"crossref","first-page":"742861","DOI":"10.3389\/fimmu.2021.742861","article-title":"Depletion of human papilloma Virus E6- and E7-oncoprotein-specific T-cell responses in women living with HIV.","volume":"12","author":"Mbuya","year":"2021","journal-title":"Front Immunol"},{"key":"R31-20260827","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections.","volume":"479-480","author":"Kahan","year":"2015","journal-title":"Virology"},{"key":"R32-20260827","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.","volume":"116","author":"Seo","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-20260827","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jid.2020.10.011","article-title":"Regulatory T cells but not IL-10 impair cell-mediated immunity in human papillomavirus E7+ hyperplastic epithelium.","volume":"141","author":"Bashaw","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R34-20260827","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5306\/wjco.v5.i4.753","article-title":"Role of IL-10 and TGF-\u03b21 in local immunosuppression in HPV-associated cervical neoplasia.","volume":"5","author":"Torres-Poveda","year":"2014","journal-title":"World J Clin Oncol"},{"key":"R35-20260827","first-page":"3604","article-title":"Imbalance of Th1\/Th2 and Th17\/Treg during the development of uterine cervical cancer.","volume":"12","author":"Lin","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"R36-20260827","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/ijc.33748","article-title":"Characterisation of anal intraepithelial neoplasia and anal cancer in HIV-positive men by immunohistochemical markers p16, Ki-67, HPV-E4 and DNA methylation markers.","volume":"149","author":"van der Zee","year":"2021","journal-title":"Int J Cancer"},{"key":"R37-20260827","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer.","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"R38-20260827","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF02258300","article-title":"Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesions.","volume":"43","author":"Litle","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"R39-20260827","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00262-012-1348-8","article-title":"Up-regulation of Foxp3 participates in progression of cervical cancer.","volume":"62","author":"Zeng","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"R40-20260827","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/vaccines13010092","article-title":"Advancing the fight against cervical cancer: the promise of therapeutic HPV vaccines.","volume":"13","author":"Zheng","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"R41-20260827","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1002\/cam4.5394","article-title":"Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: a safety analysis from a literature review and a pharmacovigilance system.","volume":"12","author":"Cui","year":"2023","journal-title":"Cancer Med"},{"key":"R42-20260827","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaoncol.2025.2374","article-title":"Outcomes of solid organ transplant recipients with advanced cancers receiving immune checkpoint inhibitors: a systematic review and individual participant data meta-analysis.","volume":"11","author":"Saleem","year":"2025","journal-title":"JAMA Oncol"},{"key":"R43-20260827","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11912-025-01675-1","article-title":"Imiquimod for anal high grade intraepithelial neoplasia: a systematic review.","volume":"27","author":"Gallio","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"R44-20260827","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of Sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"R45-20260827","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bjd\/ljaf483","article-title":"Immunosuppressive regimens and skin cancer risk in solid-organ transplant recipients.","volume":"194","author":"G\u00f3mez-Tom\u00e1s","year":"2025","journal-title":"Br J Dermatol"},{"key":"R46-20260827","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciaf086","article-title":"Effectiveness of electrocautery, topical Cidofovir, and topical Sinecatechins for the treatment of anal high-grade squamous intraepithelial lesions in persons with HIV: an open-label, randomized controlled trial.","volume":"81","author":"Burgos","year":"2025","journal-title":"Clin Infect Dis"},{"key":"R47-20260827","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer.","volume":"386","author":"Palefsky","year":"2022","journal-title":"N Engl J Med"},{"key":"R48-20260827","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1097\/MS9.0000000000004141","article-title":"Strengthening anal cancer prevention in people with HIV without immediate HRA access-correspondence.","volume":"87","author":"Nagarakanti","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"R49-20260827","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/ijc.34850","article-title":"International anal neoplasia society\u2019s consensus guidelines for anal cancer screening.","volume":"154","author":"Stier","year":"2024","journal-title":"Int J Cancer"},{"key":"R50-20260827","doi-asserted-by":"crossref","first-page":"e13590","DOI":"10.1111\/ctr.13590","article-title":"Human papillomavirus infection in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice.","volume":"33","author":"Chin-Hong","year":"2019","journal-title":"Clin Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:00:28Z","timestamp":1787803228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005891","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}